Pseudohypoaldosteronism: Clinical Trials

1 trial for Pseudohypoaldosteronism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Pseudohypoaldosteronism: new trials by email Literature Review of Pseudohypoaldosteronism trials Research Report on Pseudohypoaldosteronism

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lokelma for RAAS Maximisation in CKD & Heart Failure.
Lokelma Oral Product - Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction
Phase 3CompletedSt George's, University of London1122022-01-192026-04-27

Narrower conditions

Acute Kidney Injury (1)  ·  Hyperkalemia (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Chronic Disease (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Renal Tubular Transport, Inborn Errors (1)  ·  Urogenital Diseases (1)

Sponsors

St George's, University of London (1)

Countries

United Kingdom (1)

Top investigators

Debasish Banerjee, MD FRCP (1)